Atopic dermatitis (AD) is a complex disease with multiple causes and complex mechanistic pathways according to age of onset, severity of the illness, ethnic modifiers, response to therapy and triggers. A group of difficult-to-manage patients characterized by early-onset AD and severe lifelong disease associated with allergic asthma and/or food allergy (FA) has been identified. In this study, we focus on these severe phenotypes, analysing their links with other atopic comorbidities, and taking into account the results from recent cohort studies and meta-analyses. The main hypothesis that is currently proposed to explain the onset of allergic diseases is an epithelial barrier defect. Thus, the atopic march could correspond to an epithelial dysfunction, self-sustained by a secondary allergenic sensitization, explaining the transition from AD to allergic asthma. Furthermore, AD severity seems to be a risk factor for associated FA. Results from population-based, birth and patient cohorts show that early-onset and severe AD, male gender, parental history of asthma, and early and multiple sensitizations are risk factors leading to the atopic march and the development of asthma. The importance of environmental factors should be recognized in these high-risk children and prevention programs adapted accordingly.
| INTRODUCTION
Atopic dermatitis (AD) is the most common chronic inflammatory disorder of the skin in children. Although not life-threatening, AD hugely alters quality of life due to pruritus that may constitute a disabling condition affecting sleep as well as daily or social activities. 1, 2 Furthermore, the financial burden of the disease should not be underestimated: for example, in the United Kingdom, AD costs the healthcare system around £125 million annually. 2 Evidence from the ISAAC Study and other population-based cohorts shows that AD affects more than 20% of children in industrialized countries. 3, 4 Although primarily defined by clinical criteria, 5, 6 it is now recognized that AD is a complex disease with multiple causes and complex mechanistic pathways according to age of onset, severity of the illness, ethnic modifiers, response to therapy, and triggers (including infections, allergens, stress, and irritants). Approximately one-third of patients with AD have sensitization to allergens. 4 Most infants who present with mild AD will outgrow their skin disease later in life, and overall less than 5% of childhood AD will persist into adulthood. 4 However, a group of difficult-to-manage patients with early-onset
| Particular issues due to various definitions of AD
The United Kingdom Working Party (UKWP) defined the following diagnostic criteria for clinical research: "AD is an itchy skin disease (located on bending folds in children older than 4 years, or on limb convexities, cheeks and forehead in younger children), accompanied by xerosis, and a personal or familial history of atopy." 6 These diagnostic criteria have been validated both in hospital and in community settings and have been used in many epidemiological studies worldwide. They constitute a refinement of the Hanifin and Rajka diagnostic criteria, developed in the 1980s, which defined AD as having at least 3 of the following criteria: pruritus, lichenification, a chronically relapsing course, personal, or familial history of atopy. 5 However, some of the epidemiological studies included in this review have used other criteria to define AD or atopic eczema, and readers should be aware of these methodological differences while interpreting the findings.
Finally, a multidisciplinary team of experts addressing therapies for moderate-to-severe AD has recently reached a high level of consensus to define AD as a chronic, relapsing, non-contagious, pruritic inflammatory skin disease that occurs more commonly in children.
They go further in stating that AD is often, but not exclusively, associated with allergenic sensitization with elevated serum IgE levels and a personal or family history of atopic background (ie, allergic asthma, allergic rhinoconjunctivitis and/or FA). The experts state that a diagnosis of AD should not be ruled out in individuals lacking evidence of sensitization, and that allergic or irritant contact dermatitis and other forms of eczematous dermatitis (dyshidrotic eczema, nummular dermatitis, seborrhoeic eczema, etc.) may occur concomitantly or independently with AD. 9 The main criteria used to define AD throughout the studies retained for this review are summarized in Table 2 .
The main studies cited in this review are summarized in Tables 3   and 4 .
| Pathophysiology of AD and link with sensitization
The main current accepted hypothesis to explain the onset of AD is an epithelial barrier defect associated with a dysfunction of the skin's innate and adaptive immune systems, and dysbiosis. Thus, the atopic march could correspond to an epithelial dysfunction, self-sustained by a secondary allergenic sensitization, explaining the transition from AD to allergic asthma. The skin represents the interface between the body, especially lymphoid tissues, and the surrounding environment, preventing antigens from irrupting into circulating blood. Injuries induced by scratching or irritant topics could increase the absorption of allergens through the skin 10 Early studies [14] [15] [16] reported filaggrin loss-of-function mutations in about 20% of European patients with AD, but other filaggrin mutations have been detected in people of Asian origin. 17 The presence of filaggrin mutations has been related to more severe phenotypes (as measured by the SCORAD index) and to allergic sensitization to house dust mites and cat dander, for example. 18 During AD, both lesional and non-lesional skin exhibit a defective permeability barrier reflected by an increase in transepidermal water loss (TEWL) that persists even between flares. 19 TEWL is associated with a reduction in hydration of the stratum corneum and is positively correlated with AD severity. 20 In a mouse model, dysfunction of the epidermal barrier, and especially the stratum corneum, has been shown to induce transcutaneous sensitization and increase production of interleukin-4 and specific IgE independently of allergens or genetic background. 21 effect with allergenic exposure in AD severity leading to increased bronchial hyper-reactivity after inhaled challenge. 27 Furthermore, abnormal cutaneous response to microorganisms in children with AD could be involved in the pathways leading to asthma and allergies. Peanut sensitization seems to be more strongly associated with AD in older children, 40 or if AD is severe 41 or associated with previous egg sensitization. 42 Egg sensitization is associated with AD in most of the studies, 43, 44 
| AD phenotypes and risk of FA
Although food sensitization is frequent in children with early-onset AD, FA is not systematic. In the ORCA Study, where all the children had early-onset (<12 months) moderate-to-severe AD, 57.5%
of them had food sensitization at baseline, whereas FA was reported in only 11.7%. 47 In this study, FA was not defined by food challenge but by relevant allergic symptoms following consumption of a food allergen, associated with an IgE sensitization to the same allergen, and confirmed by an allergist. Nevertheless, the results were very similar to those from the Danish Allergy Research Cohort (DARC) which monitored children from the age of 3 months to 6 years. Children with positive skin prick tests or with positive specific IgEs to food allergens, or with a history of reported adverse reactions to food, were investigated with food challenges:
of the 122 children with AD, 52% were sensitized to food but only 15% of these children had a positive food challenge. 44 Results from the Isle of Wight birth cohort support the finding of a temporal sequence between AD and FA, with the prevalence of FA in10-year-olds being twice as high as in 1-year-olds in children with filaggrin loss-of-function mutations. 48 Severe AD seems to be a risk factor for associated FA, as demonstrated recently in a South African patient cohort. 49 Early childhood AD increases the risk of food sensitization during life as a subsequent complication in genetically predisposed children carrying filaggrin loss-of-function mutations. 48, 50 The risk of sensitization through the skin is higher when filaggrin is absent or deficient in murine models. 51 Thus, filaggrin genetic deficiency should be explored in children with early-onset and severe AD. Terms between brackets specify the criteria used to define AD.
Independently from filaggrin genetic deficiencies, genetic and ethnic predispositions for a particular form of AD linked with food sensitization and then FA are probable. Gray et al 49 in South Africa showed high rates of food sensitization and, most of all, high rates of challenge-confirmed FA (44%) in a cohort of black or mixed-race children with moderate-to-severe AD. Ashley et al 53 recently
showed that the rs9325071 variant of the skin barrier function gene SPINK5 may be a risk factor for both FA and AD.
2.5 | Risk factors for the "atopic march," a "particular phenotype of AD" (Figure 1) Atopic dermatitis is considered to be the first step towards asthma. The term "atopic march" suggests a chronological sequence during childhood, with AD predating other manifestations of atopy such as asthma and allergic rhinitis. Many studies describe this particular trajectory. 52 In a birth cohort study, Rhodes et al demonstrated the time course of atopic diseases from childhood to adulthood. 54 Abnormal reactivity to environmental triggers, present both in AD and asthma, suggests shared pathophysiological pathways. However, whether it is a temporal sequence between the diseases or a predetermined phenotype of multiple atopic comorbidities remains a matter of debate. 55 Results from the German Multicenter Atopy Study (MAS) birth cohort do not support the hypothesis of a chronological sequence of atopic diseases. 56 In this study, 1314 infants were recruited including 499 at risk of atopy due to familial history. Among them, only those who had early-onset AD (before 2 years), and early-onset wheezing (before 3 years), had an increased risk of asthma at 7 years. Conversely, most of the children who had early-onset AD without wheezing did not have an increased risk of asthma. Half of the children with early-onset AD already had recurrent wheezing far before the onset of AD. Thus, the link between AD and asthma seems more complex than ever thought before.
Furthermore, it has been well-established that the atopic march only concerns from one-third to a half of the children with AD. 7 Early-onset, severity, gender, multiple sensitization, environmental and genetic factors have been identified as risk factors.
| Early onset of AD
Early-onset AD is a risk factor for school-age asthma. In a cohort of 373 children with a familial history of asthma, an onset of AD before the age of 2 years was significantly associated with bronchial hyper-reactivity at 7. 57 Von Kobyletzki et al 58 found a 3-fold risk of asthma if onset of AD occurred before the age of 12 months, while the risk became non-significant after this age. In the Prevention of Allergy among Children in Trondheim (PACT)
case-control study, the risk of asthma increased conversely with age of onset of AD: when AD onset occurred before 3 months, the risk of asthma at the age of 6 years was 4 times higher than for an onset of AD after 3 months. 59 These results could be explained by a higher risk of sensitization in children with earlyonset AD. 36, 60 Results from the Children's HEalth and Environmental Research (CHEER) population-based cohort suggest that early-onset AD is associated with a higher risk of asthma if linked with sensitization. 61 Furthermore, in this study, this phenotype of early-onset AD was also linked with persistent AD at school-age, suggesting a particular entity grouping early-onset persistent AD, sensitization and asthma.
| Severity of AD
In a patient cohort, Gustafsson et al 46 showed that the risk of asthma at school age increased with the severity of AD. Illi et al 56 demonstrated a 6-fold increase in the risk of school-age asthma in children with severe AD in the MAS birth cohort. However, it is important to note that this severe phenotype was infrequent, representing only 1% of this birth cohort.
An Italian retrospective study, conducted in a cohort of 3-yearold children with AD, found consistent results in terms of AD severity. 62 These results have since been confirmed in birth cohorts. 58, 63 Recently, a national survey in the United States showed a strong association between severe and persistent AD, and asthma: the prevalence of asthma was 36.9% in patients with severe AD while it was only 24.3% for those with mild to moderate AD (P = .02); and the prevalence of severe asthma was also higher in cases of severe AD compared with mild AD (36% vs 5.5%, respectively, P < .0001).
Once again, the prevalence of severe AD was low in the overall population, at around 1%. 64 Finally, in a prospective Swedish study of a cohort of 115 children with AD aged under 2 years, AD severity was not only associated with a higher risk of asthma at 10 years (P = .01), but also with a higher risk of allergic rhinitis (P = .01). 
| Male gender
In the Melbourne Atopic Cohort Study (MACS), a birth cohort of 620 children with a parental history of atopy, Lowe et al 63 showed
that only boys were prone to the atopic march. According to the authors, one explanation is that AD is more severe in boys than in girls (P = .012). The effect persisted after adjustment on sensitization profile and was higher if AD was early-onset and/or severe.
Finally, von Kobyletzki et al 58 in the Dampness in Building and
Health (DBH) population-based study have also shown an excess risk of asthma and allergic rhinitis in boys with AD compared to girls.
| AD with early and multiple sensitizations
The results from the ORCA Study describe the natural history of sensitization during the first 6 years of age in children with earlyonset moderate-to-severe AD. In this cohort, food sensitization decreased over time, from 58% to 34%, whereas aeroallergen sensitization increased from 17% to 67%. Initial multiple food sensitization was the most predictive factor for the risk of developing aeroallergen sensitization at 6 years (OR 3.72 [1.68-8.30] P < .001). 37 The cohort was then investigated using an unsupervised statistical hierarchical clustering method. One cluster was characterized by a higher AD severity and frequent food (98.9%) or aeroallergen (26.2%) sensitization, often multiple (96.4% for food allergens).
This cluster, called "AD with multiple sensitizations," was the most likely to be associated with allergic asthma at the age of 6 (36.1%, P < .01). 47 In the same way, Lazic et al 66 The AD phenotype characterized by serum IgE levels ≥200 kU/L and food or aeroallergen sensitization is associated with greater disease severity. 68 This form of AD may be considered as the initial step of the atopic march, 69 with severity and early sensitization as major prognostic determinants. 46, 70 In this group of patients, immune dysregulation, including higher sensitization levels and increased Th2 cytokine expression in eczematous lesions, may be the underlying pathway leading to the expression of atopic diseases such as allergic asthma. 71 To support this hypothesis, it has been suggested that concomitant early wheeze and AD does not explain the increased risk of childhood asthma associated with AD, but rather that sensitization is the primary confounding factor in this association. 63 
| Genetic factors
Gene expression seems to differ according to the phenotype, particularly in the genes involved in human keratinocyte and filaggrin expression which is down-regulated in IgE-related AD. 68 Independently from the well-known role of filaggrin loss-of-function mutations in epithelial dysfunction, 72 other gene mutations in the epidermal differentiation complex could be involved in the severity of AD and risk of subsequent sensitization to allergens. 73, 74 It is also suspected that some polymorphisms of Th2 cytokines interfere with epidermal differentiation. 73 In a multi-stage genome-wide association study on infantile eczema followed by childhood asthma including Familial history is not always considered as a risk factor for the atopic march, although it has been demonstrated to be a risk factor for the transition from early wheezing to asthma. 58 In the ORCA Study, the cluster with the highest rate of parental history of asthma was significantly associated with asthma at the age of 6 years. 47 One hypothesis to explain this result could be a specific genetic susceptibility, involving both inflammation and epithelial barrier pathways. 80 These pollutants are suspected to induce a cutaneous oxidative stress leading to barrier dysfunction. In utero tobacco smoke exposure seems to be particularly noxious regarding the risk of occurrence of AD for some children, 81 while it could be protective for others. 82 These apparent discrepancies may be due to complex interactions between genetic background and the exposome. Transcriptomic analysis in these patients has revealed high cytokine expression in keratinocytes, especially TNF, IL-5 and TSLP.
| Role of environmental factors in AD phenotypes
Autosomal dominant hyper-IgE syndrome (also known as STAT3 deficiency) is a primary immunodeficiency disease characterized by severe eczema, recurrent infections and multiple connective tissue, skeletal and vascular abnormalities. 87 Although not all patients with STAT3 deficiency experience FA, a high rate of eosinophilic esophagitis has been described in these patients. been demonstrated to be effective in adults with moderate-tosevere AD and/or asthma and could be a promising therapy in selected children with severe AD. 9 However, further studies are needed to show that dupilumab is safe and effective in slowing or preventing the atopic march.
| CONCLUSION
Atopic dermatitis should not be seen as a single entity but rather as a condition requiring a translational approach. Clinicians should be aware of specific phenotypes which are linked with subsequent risks of asthma or other associated atopic comorbidities, such as FA.
Physicians should be particularly on the lookout for the phenotype comprising severe, early-onset AD, associated with multiple sensitization, because of a poorer respiratory prognosis during life. Association with FA should be carefully investigated in children with difficult-to-treat AD. A dysfunction in filaggrin or Th2-related cytokines or rare genetic syndromes may also explain some severe phenotypes.
